Home Cart 0 Sign in  
X

[ CAS No. 26114-12-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 26114-12-5
Chemical Structure| 26114-12-5
Chemical Structure| 26114-12-5
Structure of 26114-12-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 26114-12-5 ]

Related Doc. of [ 26114-12-5 ]

Alternatived Products of [ 26114-12-5 ]

Product Details of [ 26114-12-5 ]

CAS No. :26114-12-5 MDL No. :MFCD00600398
Formula : C11H14O2 Boiling Point : -
Linear Structure Formula :- InChI Key :CNMLOXDIFVZRNO-UHFFFAOYSA-N
M.W : 178.23 Pubchem ID :3936218
Synonyms :

Calculated chemistry of [ 26114-12-5 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.36
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 52.57
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.93
Log Po/w (XLOGP3) : 3.0
Log Po/w (WLOGP) : 2.27
Log Po/w (MLOGP) : 2.58
Log Po/w (SILICOS-IT) : 2.73
Consensus Log Po/w : 2.5

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.91
Solubility : 0.218 mg/ml ; 0.00122 mol/l
Class : Soluble
Log S (Ali) : -3.45
Solubility : 0.0636 mg/ml ; 0.000357 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.37
Solubility : 0.076 mg/ml ; 0.000427 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.27

Safety of [ 26114-12-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 26114-12-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 26114-12-5 ]
  • Downstream synthetic route of [ 26114-12-5 ]

[ 26114-12-5 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 3166-98-1 ]
  • [ 26114-12-5 ]
YieldReaction ConditionsOperation in experiment
76% for 4 h; Reflux 2-(4-propylphenyl)acetonitrile (41.0 mg, 0.257 mmol) was dissolved in 1 mL of 30percent aqueous sodium hydroxidesolution and stirred under reflux condition for 4 hours. Upon completion of the reaction, the reaction solution was acidifiedby adding 3 mL of 10percent aqueous hydrogen chloride solution and extracted with diethyl ether (3 mL33). The organic layerthus obtained was treated with anhydrous magnesium sulfate to remove water. The precipitate was filtered out and theresulting solution was concentrated by distillation under reduced pressure and purified by column chromatography toobtain 34.8 mg (0.195 mmol, 76percent) of the desired compound (balance unit of tag β).[0095] 1H NMR (300 MHz, CDCl3): d 7.24-7.13 (m, 4H), 3.16 (s, 2H), 2.58 (t, 2H, J = 7.3 Hz), 1.70-1.58 (m, 2H), 0.95(t, 3H, J = 7.4 Hz).
Reference: [1] Patent: EP2610243, 2013, A2, . Location in patent: Paragraph 0094; 0095
  • 2
  • [ 42373-38-6 ]
  • [ 26114-12-5 ]
Reference: [1] Chemische Berichte, 1943, vol. 76, p. 308,313
  • 3
  • [ 1093190-16-9 ]
  • [ 26114-12-5 ]
Reference: [1] Patent: EP2610243, 2013, A2,
  • 4
  • [ 275386-60-2 ]
  • [ 26114-12-5 ]
Reference: [1] Patent: EP2610243, 2013, A2,
  • 5
  • [ 1093190-17-0 ]
  • [ 26114-12-5 ]
Reference: [1] Patent: EP2610243, 2013, A2,
  • 6
  • [ 82657-70-3 ]
  • [ 26114-12-5 ]
Reference: [1] Patent: EP2610243, 2013, A2,
  • 7
  • [ 1360803-33-3 ]
  • [ 26114-12-5 ]
Reference: [1] Patent: EP2610243, 2013, A2,
  • 8
  • [ 1224716-84-0 ]
  • [ 26114-12-5 ]
Reference: [1] Patent: EP2610243, 2013, A2,
  • 9
  • [ 1360803-31-1 ]
  • [ 26114-12-5 ]
Reference: [1] Patent: EP2610243, 2013, A2,
  • 10
  • [ 1360803-32-2 ]
  • [ 26114-12-5 ]
Reference: [1] Patent: EP2610243, 2013, A2,
  • 11
  • [ 619-42-1 ]
  • [ 26114-12-5 ]
Reference: [1] Patent: EP2610243, 2013, A2,
  • 12
  • [ 75867-41-3 ]
  • [ 26114-12-5 ]
Reference: [1] Patent: EP2610243, 2013, A2,
  • 13
  • [ 845790-55-8 ]
  • [ 26114-12-5 ]
Reference: [1] Chemische Berichte, 1943, vol. 76, p. 308,313
  • 14
  • [ 103-65-1 ]
  • [ 26114-12-5 ]
Reference: [1] Chemische Berichte, 1943, vol. 76, p. 308,313
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 26114-12-5 ]

Aryls

Chemical Structure| 1553-60-2

[ 1553-60-2 ]

2-(4-Isobutylphenyl)acetic acid

Similarity: 0.97

Chemical Structure| 14676-52-9

[ 14676-52-9 ]

2-([1,1'-Biphenyl]-2-yl)acetic acid

Similarity: 0.97

Chemical Structure| 644-36-0

[ 644-36-0 ]

o-Tolylacetic acid

Similarity: 0.97

Chemical Structure| 19806-17-8

[ 19806-17-8 ]

2,2'-(1,3-Phenylene)diacetic acid

Similarity: 0.97

Chemical Structure| 7325-46-4

[ 7325-46-4 ]

2,2'-(1,4-Phenylene)diacetic acid

Similarity: 0.97

Carboxylic Acids

Chemical Structure| 1553-60-2

[ 1553-60-2 ]

2-(4-Isobutylphenyl)acetic acid

Similarity: 0.97

Chemical Structure| 14676-52-9

[ 14676-52-9 ]

2-([1,1'-Biphenyl]-2-yl)acetic acid

Similarity: 0.97

Chemical Structure| 644-36-0

[ 644-36-0 ]

o-Tolylacetic acid

Similarity: 0.97

Chemical Structure| 19806-17-8

[ 19806-17-8 ]

2,2'-(1,3-Phenylene)diacetic acid

Similarity: 0.97

Chemical Structure| 7325-46-4

[ 7325-46-4 ]

2,2'-(1,4-Phenylene)diacetic acid

Similarity: 0.97